Sabin Begins Marburg Vaccine Trial in U.S.

Sabin Begins Marburg Vaccine Clinical Trial in U.S. WASHINGTON, April 16, 2025 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the first participants in Melbourne, Florida. This trial builds on ongoing Phase 2 testing in Kenya and […]
Read more